Head of Immunodiagnostics and Generation Technology

Head of Immunodiagnostics and Next Generation Technology

We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place.

To fully realize Pfizer’s purpose – Breakthroughs that change patients’ lives – we have established a clear set of expectations regarding “what” we need to achieve for patients and “how” we will go about achieving those goals.

Pfizer Research & Development serves as the beating heart of Pfizer's trailblazing product pipeline, the essence of our mission to bring life‑changing medicines to the world.

Pfizer offers competitive compensation and benefits programs designed to meet the diverse needs of our colleagues.

As a Senior Leader within our Vaccines R&D Clinical Immunology and Diagnostics organization, you will envision and implement next‑generation immunodiagnostics strategies. Reporting to the Head of Clinical Diagnostics, you will drive novel, high‑throughput ligand binding assay (LBA) strategies outside of conventional plate‑based assays—focusing heavily on automation, speed, and high precision.

You will lead a high‑performing team developing and maintaining immunodiagnostic assays to support vaccine clinical trials and epidemiological studies. You will serve as the primary immunology and assay development Subject Matter Expert (SME) for vaccine program teams. You will leverage your deep end‑to‑end expertise in assay life cycles, robotic sample handling, clinical batching, and analytical/clinical validations under GCLP/cGMP guidelines.

• Envision and execute next‑generation ligand binding assay (LBA) strategies, driving high‑throughput, automated, and rapid‑completion alternatives to traditional plate‑based assays.
• Keep abreast of scientific and technological breakthroughs; identify and in‑license/in‑house promising new diagnostic platforms.

• Set objectives for and manage multiple assay development projects (serological, immunodiagnostic, and toxicological).
• Drive the prioritization of clinical epidemiological studies by optimizing logistical testing resources.
• Author and review high‑level technical documents, validations, regulatory responses, and scientific publications.

• Collaborate across internal Vaccines R&D teams and external partners to integrate cutting‑edge testing technologies into clinical strategies.
• Lead technology transfers and represent the department in key scientific and strategic discussions.

• Direct and mentor a diverse team of scientists, including direct management of multiple subordinate managers.
• Ensure all laboratory work and clinical testing strictly adhere to Pfizer values, SOPs, and GCLP/cGMP standards.

• PhD in Immunology or a closely related biological field.
• 5+ years of industry experience leading the development of advanced tools and assays and the implementation of cutting edge technologies.
• Experience managing other managers and mentoring junior scientists.

• Deep expertise in assay development and lifecycle management (from concept/design to long‑term sustainability).
• Strong background in robotic sample handling systems, clinical batching, Design of Experiments (DoE), and general biostatistical analysis.
• Expert knowledge of analytical/clinical validations under GCLP and/or cGMP guidelines.

• Proficiency with LIMS, DoE software, and standard enterprise suites.

• Strong publication record (primary author) and
• Experience presenting concise, high‑level data to senior leadership.

• Experience leveraging AI, machine learning, or advanced algorithmic scheduling software to optimize high‑throughput laboratory automation and automated assay data analysis pipelines.
• Experience interacting with/responding to regulatory agencies.

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to…